Inflammation and atherosclerosis: disease modulating therapies (Q39360950)

11 September 2017

Inflammation and atherosclerosis: disease modulating therapies (English)

1 reference

11 September 2017

0 references

1 reference

Mahesh J Patel

1

1 reference

PubMed ID

23979859

11 September 2017

Michael A Blazing

series ordinal

2

1 reference

PubMed ID

23979859

11 September 2017

language of work or name

1 reference

1 December 2013

1 reference

Current treatment options in cardiovascular medicine

11 September 2017

1 reference

11 September 2017

15

1 reference

11 September 2017

6

1 reference

11 September 2017

681-695

1 reference

https://scigraph.springernature.com/pub.10.1007/s11936-013-0268-z

11 September 2017

0 references

cites work

Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Sequestration of aggregated low-density lipoproteins by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Phospholipase A2 inhibitors in atherosclerosis: the race is on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A₂ (Lp-PLA₂): a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Role of Monocytes in Atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Does therapeutic intervention achieve slowing of progression or bona fide regression of atherosclerotic lesions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

The discovery of cellular immunity in the atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Adaptive immunity and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Molecular bases of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Atherogenesis in rheumatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Risk of myocardial infarction and stroke after acute infection or vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

C-reactive protein levels and outcomes after statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Genetically elevated C-reactive protein and ischemic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Aspirin dose for the prevention of cardiovascular disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Methotrexate in atherogenesis and cholesterol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Treatment with methotrexate inhibits atherogenesis in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

From asthma to atherosclerosis--5-lipoxygenase, leukotrienes, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Perspectives and opportunities for nanomedicine in the management of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Study design and rationale for the Stabilization of pLaques usIng Darapladib—Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-013-0268-Z

Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta

21 January 2018

1 reference

12 December 2020

Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis

1 reference

12 December 2020

Independent impact of gout on mortality and risk for coronary heart disease

1 reference

12 December 2020

An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium

1 reference

12 December 2020

Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis

1 reference

12 December 2020

Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study

1 reference

12 December 2020

Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction

1 reference

12 December 2020

The role of adaptive T cell immunity in atherosclerosis

1 reference

12 December 2020

Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects.

1 reference

12 December 2020

Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region

1 reference

12 December 2020

How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH

1 reference

12 December 2020

Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin

1 reference

12 December 2020

Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome.

1 reference

12 December 2020

Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist

1 reference

12 December 2020

C-reactive protein fifty years on

1 reference

12 December 2020

Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial

1 reference

12 December 2020

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

1 reference

12 December 2020

Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice

1 reference

12 December 2020

A review of tocilizumab treatment in 122 rheumatoid arthritis patients included in the Tsurumai Biologics Communication Registry (TBCR) Study

1 reference

12 December 2020

Risk of Myocardial Infarction in Patients With Psoriasis

1 reference

12 December 2020

10.1007/S11936-013-0268-Z

Identifiers

DOI

1 reference

11 September 2017

1 reference

PubMed ID

23979859